FrancophonIA/ELRC3.0 huggingface dataset:
English: Once you remove the cap, do not recap the syringe.
Slovenian: Ko enkrat odstranite pokrovček z injekcijske brizge, ga ne smete več namestiti.
English: Fewer subjects underwent colectomy in the 5 mg/kg infliximab group (28/242 or 11.6% [N.S.]) and the 10 mg/kg infliximab group (18/242 or 7.4% [p=0.011]) than in the placebo group
Slovenian: Ugotovili so, da je bilo treba v terapevtskih skupinah, ki sta prejemali po 5 mg/kg infliksimaba (28/242 ali 11,6 % [nesignifikantno]) oziroma po 10 mg/kg infliksimaba
English: Under aseptic conditions, each Remsima vial should be reconstituted with 10 mL of water for injections, using a syringe equipped with a 21-gauge (0.8 mm) or smaller needle.
Slovenian: Uporabite injekcijsko brizgo z iglo 0,8 mm (21 G) ali tanjšo.
English: Do not reuse the pen in this case.
Slovenian: tem primeru ga ne vračajte ponovno v hladilnik.
English: Remsima contains the active substance infliximab.
Slovenian: Zdravilo Remsima vsebuje učinkovino infliksimab.
English: Each new injection site should be at least
Slovenian: Vsako novo mesto injiciranja mora biti od prejšnjega oddaljeno vsaj 3 cm.
English: (up to 22 years of age) treated with TNF-blocking agents (initiation of therapy ≤18 years of age),
Slovenian: Pri otrocih, mladostnikih in mlajših odraslih (do 22 let starosti), ki so se zdravili z zaviralci TNF
English: In post-marketing experience, cases of anaphylactic-like reactions, including laryngeal/pharyngeal oedema and severe bronchospasm, and seizure have been associated with infliximab intravenous administration (see section 4.4).
Slovenian: V okviru izkušenj v obdobju trženja je bila uporaba intravenskega infliksimaba povezana s primeri anafilaktoidnih reakcij, vključno z edemom grla ali žrela in hudega bronhospazma, ter epileptičnimi napadi (glejte poglavje 4.4).
English: Figure A
Slovenian: Slika E
English: Signs of a local injection site reaction can include redness, pain, itching, swelling, hardness, bleeding, bruising, cold sensation, irritation, tingling sensation, ulcer, hives, rash and scab on the skin of the injection site.
Slovenian: bolečino, srbečico, oteklino, zatrdlino, krvavitev, modrice, občutek hlada, draženje, občutek ščemenja, ulkus, koprivnico, izpuščaj in krasto na koži na mestu injiciranja.
English: After preparation each mL contains 10 mg of infliximab.
Slovenian: Po pripravi en ml vsebuje 10 mg infliksimaba.
English: • 4 prefilled syringes with automatic needle guard (1 mL sterile solution) with 4 alcohol pads.
Slovenian: • 4 napolnjene injekcijske brizge s samodejnim ščitnikom za iglo (1 ml sterilne raztopine) s 4 alkoholnimi zloženci.
English: Week 54 among patients who were receiving corticosteroids at baseline.
Slovenian: in 175 bolnikov v skupini, ki je prejemala zdravilo Remsima v intravenski obliki.
English: Read carefully these instructions before using the Remsima syringe.
Slovenian: Pred uporabo injekcijske brizge z zdravilom Remsima natančno preberite ta navodila.
English: Clear to opalescent, colourless to pale brown solution.
Slovenian: Bistra do opalescentna in brezbarvna do bledo rjava raztopina.
English: Remsima is a clear to opalescent, colourless to pale brown solution which is supplied as a single use pre-filled pen.
Slovenian: Zdravilo Remsima je bistra do opalescentna in brezbarvna do bledo rjava raztopina, ki je na voljo v napolnjenem injekcijskem peresniku za enkratno uporabo.
English: Acute infusion reactions including anaphylactic reactions may develop during (within seconds) or within a few hours following infusion.
Slovenian: Akutna reakcija, vključno z anafilaktično reakcijo, lahko nastopi med infuzijo (t.j.
English: Endophthalmitis
Slovenian: Pediatrična
English: b Absence of any draining fistulas.
Slovenian: ≥ 4 tednov b Bolnik nima nobenih fistul z izcedkom
English: ** PASI 75 response for IMPACT not included due to low N; p<0.001 for infliximab vs. placebo at week 24 for IMPACT 2.
Slovenian: b Z upoštevanjem bolnikov s PASI ≥ 2,5 na začetku študije IMPACT in tistih s psoriatično prizadetostjo kože ≥ 3 % BSA na začetku študije IMPACT 2 ** Odziv PASI 75 iz študije IMPACT ni vključen zaradi majhnega števila N; p< 0,001 za infliksimab v primerjavi s placebom v 24. tednu v študiji IMPACT 2 V študijah IMPACT in IMPACT 2 so opazili klinični odziv že v 2. tednu, ohranjen pa je bil tudi še v 98. tednu in 54. tednu.
English: Remsima 120 mg solution for injection in pre-filled pen Remsima 120 mg solution for injection in single-use pre-filled pen for patient use containing a pre-filled syringe.
Slovenian: Zdravilo Remsima 120 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku Zdravilo Remsima 120 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku, ki vsebuje napolnjeno injekcijsko brizgo, za enkratno uporabo za samoinjiciranje.
English: • Eye problems including blurred or reduced vision, puffy eyes or sties
Slovenian: • težave z očmi, vključno z zamegljenim vidom ali slabovidnostjo, otečene oči ali ječmen na očesu, okužba roženice (prozornega dela očesa)
English: Keep the pre-filled syringe in its package in order to protect from light.
Slovenian: Napolnjeno injekcijsko brizgo shranjujte v zunanji ovojnini za zagotovitev zaščite pred svetlobo
English: • Do not shake the syringe at any time.
Slovenian: • Injekcijske brizge ne smete nikoli stresati.
English: • Tell your doctor straight away if you get symptoms of low blood counts during treatment with Remsima.
Slovenian: Takoj obvestite zdravnika, če se med zdravljenjem z zdravilom Remsima pojavijo simptomi nizkega števila krvnih celic.
English: Pyelonephritis.
Slovenian: bolnikov-let.
English: Signs include a fever, feeling tired, (persistent) cough, shortness of breath, weight loss, night sweats, diarrhoea, wounds, dental problems, burning when urinating or ‘flu-like' signs.
Slovenian: Ti znake so zvišana telesna temperatura, utrujenost, (trdovraten) kašelj, kratka sapa, izguba telesne mase, nočno potenje, driska, rane, težave z zobmi,
English: • 4 prefilled syringes (1 mL sterile solution) with 4 alcohol pads.
Slovenian: • 4 napolnjeni injekcijski peresniki (1 ml sterilne raztopine) s 4 alkoholnimi zloženci.
English: Dispose of the syringe (see Figure H).
Slovenian: Odložite injekcijsko brizgo (glejte sliko H).
English: Median (Interquartile range)
Slovenian: (pregledani bolniki) srednja vr.
English: Your baby should not receive a ‘live vaccine', such as BCG (used to prevent tuberculosis) within 6 months after birth.
Slovenian: Vaš dojenček v obdobju 6 mesecev po rojstvu ne sme prejeti "živega cepiva", kot je cepivo
English: 10 mg/kg q 4 wks
Slovenian: 5 mg/kg 10 mg/kg Združeni podatki
English: Remsima 120 mg solution for injection in pre-filled syringe infliximab
Slovenian: Remsima 120 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku infliksimab
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON FOR PRE-FILLED PEN
Slovenian: PODATKI NA ZUNANJI OVOJNINI ZUNANJA OVOJNINA ZA NAPOLNJEN INJEKCIJSKI PERESNIK
English: Sodium dihydrogen phosphate monohydrate Disodium phosphate dihydrate
Slovenian: FARMACEVTSKI PODATKI 6.1 Seznam pomožnih snovi saharoza polisorbat 80 natrijev dihidrogenfosfat monohidrat natrijev hidrogenfosfat dihidrat
English: • 2 prefilled syringes with automatic needle guard (1 mL sterile solution) with 2 alcohol pads.
Slovenian: • 2 napolnjeni injekcijski brizgi s samodejnim ščitnikom za iglo (1 ml sterilne raztopine) z 2 alkoholnima zložencema.
English: • 1 prefilled syringe with automatic needle guard (1 mL sterile solution) with 2 alcohol pads.
Slovenian: • 1 napolnjena injekcijska brizga s samodejnim ščitnikom za iglo (1 ml sterilne raztopine) z 2 alkoholnima zložencema.
English: • Keep this medicine out of the sight and reach of children.
Slovenian: • Zdravilo shranjujte nedosegljivo otrokom.
English: b. Lift the pen from the injection site (see Figure H).
Slovenian: b. Injekcijski peresnik umaknite z mesta injiciranja (glejte Slika H).
English: Reactivation of hepatitis B has occurred in patients receiving a TNF-antagonist including infliximab, who are chronic carriers of this virus.
Slovenian: Pri bolnikih, ki so prejemali zaviralec TNF, na primer infliksimab, in ki so bili kronični prenašalci virusa hepatitisa B, je prišlo do reaktivacije hepatitisa B. V nekaterih primerih je prišlo celo do smrti bolnika.
English: • Tell your doctor straight away if you develop symptoms of lupus during treatment with Remsima.
Slovenian: Takoj obvestite zdravnika, če se med zdravljenjem z zdravilom Remsima pojavijo simptomi lupusa.
English: The primary endpoint was the proportion of patients who experienced a clinical response, defined as a decrease in CDAI by ≥70 points from baseline at the 4-week evaluation and without an increase in the use of medicinal products or surgery for Crohn's disease.
Slovenian: za ≥ 70 točk od izhodiščne vrednosti ob pregledu v 4. tednu zdravljenja, z nespremenjeno potrebo po zdravilih ali operativnih posegih za zdravljenje Crohnove bolezni.
English: Patients must be monitored closely for infections including tuberculosis before, during and after treatment with infliximab.
Slovenian: Okužbe Pred, med in po zdravljenju z infliksimabom morate bolnike skrbno spremljati, da ugotovite morebitne okužbe, vključno s tuberkulozo.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS LABEL FOR PRE-FILLED SYRINGE WITH AUTOMATIC NEEDLE GUARD
Slovenian: NALEPKA NA NAPOLNJENI INJEKCIJSKI BRIZGI S SAMODEJNIM ŠČITNIKOM ZA IGLO
English: Controla
Slovenian: pielonefritis
English: Please read the Remsima ‘Package Leaflet' carefully before you start using this medicine.
Slovenian: Preden začnete uporabljati to zdravilo, natančno preberite navodilo za uporabo.
English: Mean ± SDa
Slovenian: Bat brizge
English: Median
Slovenian: ZDRAVILA
English: Peripheral blood mononuclear cells (PBMC) from infliximab-treated patients showed undiminished proliferative responsiveness to stimuli compared with untreated patients, and no substantial changes in cytokine production by stimulated PBMC were observed following treatment with infliximab.
Slovenian: Ne število limfocitov v periferni krvi ne njihov proliferacijski odziv na mitogeno stimulacijo in vitro se pri bolnikih, zdravljenih z infliksimabom, nista bistveno zmanjšala v primerjavi s celicami nezdravljenih bolnikov
English: • You may get infections more easily when you are being treated with Remsima.
Slovenian: • Med zdravljenjem z zdravilom Remsima se lahko poveča dovzetnost za okužbe.
English: • In case you have received Remsima while you were pregnant, it is important that you inform your baby's doctor about it before your baby receives any vaccine.
Slovenian: Remsima, je pomembno, da o tem obvestite zdravnika vašega dojenčka, preden dojenček prejme katero koli cepivo.
English: • Pain.
Slovenian: (HBV).
English: Each 1 ml single dose pre-filled syringe contains 120 mg of infliximab.
Slovenian: Ena 1-ml enoodmerna napolnjena injekcijska brizga vsebuje 120 mg infliksimaba.
English: • 4 prefilled pens (1 mL sterile solution) with 4 alcohol pads.
Slovenian: • 4 napolnjene injekcijske brizge (1 ml sterilne raztopine) s 4 alkoholnimi zloženci.
English: At week 16, 47 placebo patients with <10% improvement from baseline in both swollen and tender joint counts were switched to infliximab induction (early escape).
Slovenian: < 10 % izboljšanjem stanja glede na začetek študije - tako glede števila oteklih kot bolečih sklepov prešlo na uvedbo infliksimaba (zgodnji umik).
English: Remsima 120 mg solution for injection in pre-filled syringe with automatic needle guard Remsima 120 mg solution for injection in single-use pre-filled syringe with automatic needle guard.
Slovenian: Zdravilo Remsima 120 mg raztopina za injiciranje v napolnjeni injekcijski brizgi za enkratno uporabo s samodejnim ščitnikom za iglo.
English: Do not use the pen if:
Slovenian: Po potrebi namestite obliž.
English: • Some patients who have received TNF-blockers, including infliximab have developed a rare type of cancer called hepatosplenic T-cell lymphoma.
Slovenian: • Pri nekaterih bolnikih, ki so prejemali zaviralce TNF, vključno z infliksimabom, se je pojavila redka oblika raka, ki mu pravimo hepatosplenični limfom celic T. Od teh bolnikov je bila večina najstnikov ali mladih moških in večina je imela Crohnovo bolezen ali ulcerozni kolitis.
English: In phase III clinical studies, 18% of infliximab-treated patients compared with 5% of placebo-treated patients experienced an infusion-related reaction.
Slovenian: V kliničnih študijah faze III se je pri 18 % bolnikov,
English: • Side effect due to an infusion
Slovenian: • neželeni učinek zaradi infuzije • bolečine.
English: At
Slovenian: Bat
English: Concurrent use of stable doses of oral corticosteroids (≤10 mg/day) and/or NSAIDs was permitted, and folate supplementation was given.
Slovenian: Sočasna uporaba stalnih odmerkov peroralnih kortikosteroidov (≤ 10 mg/dan)
English: Children who took infliximab for Crohn's disease showed some differences in side effects compared with adults who took infliximab for Crohn's disease.
Slovenian: Dodatni neželeni učinki pri otrocih in mladostnikih Neželeni učinki pri otrocih in odraslih, ki so prejemali infliksimab za zdravljenje Crohnove bolezni, so se nekoliko razlikovali.
English: In one of the study arms (group 2, n=329), patients with an inadequate response were allowed to dose titrate with 1.5 mg/kg increments from 3 up to 9 mg/kg.
Slovenian: (skupina 2, n=329) so bolnikom z nezadostnim odzivom na zdravilo omogočili titracijo t.j.
English: Date of Remsima therapy initiation:
Slovenian: Zdravilo Remsima uporabljajte:
English: 5 mg/kg given as an intravenous infusion followed by an additional 5 mg/kg infusion 2 weeks after the first infusion.
Slovenian: Zmerno do močno aktivna Crohnova bolezen Odmerek je 5 mg/kg v obliki intravenske infuzije, čemur naj sledi dodatna infuzija v odmerku 5 mg/kg 2 tedna po prvi infuziji.
English: • Urinary tract infection
Slovenian: • Injekcijski peresnik
English: In patients treated with infliximab, an invasive fungal infection such as aspergillosis, candidiasis, pneumocystosis, histoplasmosis, coccidioidomycosis or blastomycosis should be suspected if they develop a serious systemic illness, and a physician with expertise in the diagnosis and treatment of invasive fungal infections should be consulted at an early stage when investigating these patients.
Slovenian: kokcidioidomikoza ali blastomikoza, poleg tega pa je pri teh bolnikih že zgodaj v poteku preiskav potreben posvet z zdravnikom, ki ima strokovno znanje iz diagnostike in zdravljenja invazivnih glivičnih okužb.
English: Each Remsima vial contains 100 mg infliximab.
Slovenian: Remsima vsebuje 100 mg infliksimaba.
English: • Some patients receiving infliximab have developed serious liver problems.
Slovenian: Težave z jetri • Pri nekaterih bolnikih, ki prejemajo zdravilo Remsima, so se pojavile resne težave z jetri.
English: Talk to your doctor before or during treatment with Remsima if you have:
Slovenian: Pred ali med zdravljenjem z zdravilom Remsima, se v naslednjih primerih posvetujte z zdravnikom: Predhodno ste se že zdravili s katerim koli zdravilom, ki vsebuje infliksimab
English: Ελλάδα
Slovenian: po NYHA).
English: The incidence of systemic injection reactions (e.g. rash, pruritus, flushing and oedema) was 1.2 per 100 patient-years in the Remsima subcutaneous group (from Week 6) and 2.1 per 100 patient-years in the Remsima intravenous group who switched to Remsima subcutaneous administration (from Week 30).
Slovenian: V skupini, ki je prejemala zdravilo Remsima v intravenski obliki (od 6. tedna naprej) in ki je prešla na zdravilo Remsima v subkutani obliki (od 30. tedna naprej), je bila pojavnost sistemskih z injiciranjem povezanih reakcij (npr. izpuščaj, pruritus, rdečica in edem) 1,2 na 100 bolnikov-let in 2,1 na 100
English: Read carefully these instructions before using the Remsima pen.
Slovenian: Pred uporabo injekcijskega peresnika z zdravilom Remsima natančno preberite ta navodila.
English: Package leaflet: Information for the user Remsima 100 mg powder for concentrate for solution for infusion infliximab
Slovenian: Navodilo za uporabo Remsima 100 mg prašek za koncentrat za raztopino za infundiranje infliksimab
English: Remsima is however, diluted in sodium chloride 9 mg/ml (0.9%) solution for infusion.
Slovenian: (0,9-%) raztopino natrijevega klorida za infundiranje.
English: Indication Number of patients2 Median follow-up (wks)3
Slovenian: Indikacija Število bolnikov2
English: Before treatment with Remsima
Slovenian: Pred zdravljenjem s tem zdravilom
English: • 1 prefilled syringe (1 mL sterile solution) with 2 alcohol pads.
Slovenian: • 1 napolnjena injekcijska brizga (1 ml sterilne raztopine) z 2 alkoholnima zložencema.
English: The syringe inside the pen is made from type 1 glass with a plunger stopper (flurotec-coated elastomer) and needle with a rigid needle shield.
Slovenian: Injekcijska brizga v injekcijskem peresniku je izdelana iz stekla tipa I z batnim zamaškom (iz elastomera s prevleko
English: Keep the pre-filled pen in its package in order to protect from light.
Slovenian: Shranjujte v zunanji ovojnini za zagotovitev zaščite pred svetlobo.
English: The solution must not be used if opaque particles, discolouration, or other foreign particles are present.
Slovenian: Raztopine ne smete uporabiti, če so prisotni neprosojni delci,
English: • 2 prefilled syringes (1 mL sterile solution) with 2 alcohol pads.
Slovenian: • 2 napolnjeni injekcijski brizgi (1 ml sterilne raztopine) z 2 alkoholnima zložencema.
English: 3 mg/kg q 4 wks
Slovenian: 3 mg/kg
English: ACCENT II (Week-14 responders)
Slovenian: ACCENT II (bolniki z odzivom v 14. tednu) Vzdrževalno zdravljenje s placebom (n = 99)
English: Vaginitis.
Slovenian: Ohišje
English: b all infliximab doses given in combination with methotrexate and folate with some on corticosteroids and/or NSAIDs c p <0.001, for each infliximab treatment group vs. control d greater values indicate more joint damage.
Slovenian: b Vsi odmerki infliksimaba so bili v kombinaciji z metotreksatom in folatom, nekaj tudi s kortikosteroidi in/ali NSAID.
English: No dose recommendations can be made (see section 5.2).
Slovenian: Infliksimabom pri teh populacijah bolnikov niso proučevali, zato ni mogoče podati priporočil za odmerjanje (glejte poglavje 5.2).
English: Carriers of HBV who require treatment with infliximab should be closely monitored for signs and symptoms of active HBV infection throughout therapy and for several months following termination of therapy.
Slovenian: Pri tistih bolnikih, ki imajo pozitiven izvid na okužbo z virusom HBV, je priporočljiv tudi posvet z zdravnikom, ki ima izkušnje z zdravljenjem hepatitisa B. Prenašalce virusa HBV, ki potrebujejo zdravljenje z infliksimabom, je treba ves čas zdravljenja in še več mesecev po prekinitvi oz. zaključku zdravljenja skrbno spremljati, da pri njih ugotovite morebitne znake in simptome aktivne okužbe z virusom HBV. Ni zadostnih podatkov o zdravljenju prenašalcev virusa HBV s protivirusno terapijo ob uporabi zaviralec TNF za preprečevanje reaktivacije hepatitisa B. Pri bolnikih, pri katerih se ponovno aktivira okužba s HBV, je treba infliksimab ukiniti in uvesti učinkovito protivirusno terapijo z ustreznimi podpornimi ukrepi.
English: Moderately to severely active Crohn's disease
Slovenian: Začetno zdravljenje pri aktivni Crohnovi bolezni s fistulami
English: Percentage of subjects with mucosal healing
Slovenian: Odstotek preiskovancev s celjenjem sluznice
English: Conjunctivitis
Slovenian: Odziv
English: Mundipharma Pharmaceuticals B.V. Tel: + 31 33 450 8270
Slovenian: Tel: + 31 33 450 8270
English: SC
Slovenian: Z
English: • 1 prefilled pen (1 mL sterile solution) with 2 alcohol pads.
Slovenian: • 1 napolnjen injekcijski peresnik (1 ml sterilne raztopine) z 2 alkoholnima zložencema.
English: d p = 0.030 and <0.001 for the 3 mg/kg and 6 mg/kg treatment groups respectively vs. placebo + MTX.
Slovenian: do 54. tednac Srednja vrednost ± SDd a p < 0,001 za vsako terapevtsko skupino, ki je prejemala infliksimab, v primerjavi s kontrolno skupino b večje vrednosti pomenijo večjo okvaro sklepov c HAQ = vprašalnik za oceno zdravstvenega stanja; večje vrednosti pomenijo manjšo okvaro sklepov d p = 0,030 in < 0,001 za terapevtski skupini, ki sta prejemali 3 mg/kg in 6 mg/kg v primerjavi s placebom + MTX
English: PASI 75 response** * ITT-analysis where subjects with missing data were included as non-responders.
Slovenian: PASI 75** * Analiza namere zdravljenja (ITT), v kateri so preiskovance brez nekaterih podatkov šteli med neodzivne bolnike a Podatki za 98. teden iz študije IMPACT vključujejo seštevek bolnikov, ki so prešli s placeba na infliksimab, in tiste bolnike na infliksimabu, ki so jih vključili v odprt podaljšek študije.
English: Package leaflet: Information for the user Remsima 120 mg solution for injection in pre-filled syringe infliximab
Slovenian: Navodilo za uporabo Remsima 120 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku infliksimab
English: Infliximab has been associated with systemic injection reactions, anaphylactic shock and delayed hypersensitivity reactions (see section 4.8).
Slovenian: anafilaktičnim šokom in poznimi preobčutljivostnimi reakcijami (glejte poglavje 4.8).
English: ‘Re-administration' below and section 4.4).
Slovenian: T (glejte poglavj 4.8).
English: Please follow these steps:
Slovenian: Prosimo, da sledite naslednjim korakom:
English: Ποζειδώνος 77 174 55 Άλιμος, Αηηική
Slovenian: Ποσειδώνος 77 174 55 Άλιμος, Αττική
English: The following dosing table indicates what volume to administer depending on the weight of the dog:
Slovenian: Naslednja tabela za odmerjanje prikazuje, kakšen volumen je treba dati v odvisnosti od teže psa:
English: The active substance in Rheumocam is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) 37/2010:
Slovenian: Učinkovina zdravila Rheumocam je dovoljena učinkovina, kot je navedena v tabeli 1 (dovoljene snovi) priloge Uredbe Komisije (EU) št. 37/2010:
English: Once in place the insert will not need to be removed
Slovenian: Ko v mestu vložek ne bo treba odstraniti
English: To ensure correct dosage, body weight should be determined as accurately as possible to avoid underdosing or overdosing.
Slovenian: Da bi zagotovili pravilno odmerjanje, telesne teže, je treba telesno težo določiti čim bolj natančno, da bi se izognili prenizkemu ali previsokemu odmerjanju.
English: Dose scheme for the maintenance dose:
Slovenian: Shema odmerjanja za vzdrževalni odmerka:
English: This product is only for use in horses weighing between 500 and 600 kg.
Slovenian: Ta izdelek je samo za uporabo pri konjih, ki tehtajo med 500 in 600 kg .
English: Date of last renewal: 18/12/2012.
Slovenian: Datum podaljšanja dovoljenja za promet: 18/12/2012.
English: Shelf life after incorporation into muesli feed: use immediately.
Slovenian: Rok uporabnosti po vključitvi v müsli krme: uporabite takoj.
English: Push the plunger until all contents of the syringe have been dispensed onto the food.
Slovenian: Potiskajte bat, dokler niso vsi Vsebina brizge odpravijo na hrano
English: Date of first authorisation: 10/01/2008 Date of last renewal: 18/12/2012
Slovenian: Datum pridobitve dovoljenja za promet: 10/01/2008 Datum zadnjega podaljšanja dovoljenja za promet: 18/12/2012
English: Česká republika Orion OYJ Zelený pruh 95/97, 140 00, Praha, ČR
Slovenian: Orion OYJ Zelený pruh 95/97, 140 00, Praha, ČR
English: Non-infectious locomotor disorders.
Slovenian: Neinfekcijske lokomotorne motnje
English: Paper foil sachets (paper/PE/alu/PE) containing 1.5 g granules per sachet in a cardboard box with 100 sachets.
Slovenian: Vrečke papir folije (papir/PE/alu/PE), ki vsebuje 1,5 g zrnca na vrečko v kartonasti škatli s 100 vrečk .
English: Rheumocam chewable tablets can be administered with or without food, are flavoured and are taken by most dogs voluntarily.
Slovenian: Žvečljivo tablete Rheumocam lahko dajemo s hrano ali brez nje, imajo dodano aromo in jih večina psov, vzame prostovoljno.